IP Library Granted Patent US 8,497,301
Granted Patent B2
US 8,497,301 · App. 13/470,825 · Granted Jul 30, 2013

Hydroxyl compounds and compositions for cholesterol management and related uses

Inventors: Jean-Louis Henri Dasseux (Brighton, MI); Carmen Daniela Oniciu (Ann Arbor, MI)
Assignee: Esperion Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,497,301
App. No.
13/470,825
Granted
Jul 30, 2013
Kind
B2
Abstract

The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

Claims (3)

1. A method of lowering LDL levels, which comprises administering to a patient in need thereof a therapeutically effective amount of a compound of the formula

or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein the method comprises administering to the patient a therapeutically effective amount of a compound of the formula

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2024
From: EIGER III SA LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 067963/0094 →
SECURITY INTEREST Recorded Jun 28, 2019
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 049623/0629 →
MERGER Recorded Oct 14, 2014
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033946/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2013
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 029984/0863 →
Continuity (5)
Continuation 12870184 · Aug 27, 2010
Division 11680105 · Feb 28, 2007
Division 10743470 · Dec 23, 2003
Provisional Application 60441795 · Jan 23, 2003
Related Publication 20120225908A1 · Sep 6, 2012